Ir a las Transacciones
Salud | Private Equity

Atida has completed a structuring and placement

Atida has completed a structuring and placement in the private equity fund Europe Pharma Online.

Atida is an online health company that is transforming the landscape of health and well-being across Europe. With online pharmacies and parapharmacies across nine countries and more than 4,000 active customers, Atida is on a mission to help Europeans make better decisions about their health by providing a trusted and personalized health ecosystem that caters to both proactive and curative needs.

Oaklins’ team in Chile acted as the structuring and placement agent in the private equity fund Europe Pharma Online.

Contáctese con el equipo de la transacción

Agustin Achondo

Director
Santiago, Chile
Oaklins LarrainVial

Transacciones relacionadas

Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard
Private Equity | Consumo & Retail | Otras Industrias

Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard

Bluegem Capital Partners and AREV Partners have successfully completed the acquisition of the prestigious Groupe Pinard from IK Partners.

Aprenda más
Lumiforte partners with Kartesia to propel global growth and innovation
Private Equity | Agricultura | Otras Industrias

Lumiforte partners with Kartesia to propel global growth and innovation

Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.

Aprenda más
PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
Salud

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

Aprenda más